APOE and Parkinson disease: Our results suggest the need for further investigation on the possible influence of FOXO3A/FNDC5 interactions and APOE/FNDC5 interactions with EL, but also with other age-related diseases such as atherosclerosis, Alzheimer’s, or Parkinson’s disease.